Variant report
Variant | esv2762657 |
---|---|
Chromosome Location | chr7:19178075-19180700 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:4)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:4 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | MAFK | chr7:19180684-19180875 | HepG2 | liver: | n/a | n/a |
2 | MAFK | chr7:19180205-19180356 | HepG2 | liver: | n/a | chr7:19180239-19180250 chr7:19180238-19180253 chr7:19180239-19180250 chr7:19180237-19180251 |
3 | MAFK | chr7:19180165-19180399 | HepG2 | liver: | n/a | chr7:19180239-19180250 chr7:19180238-19180253 chr7:19180239-19180250 chr7:19180237-19180251 |
4 | TCF7L2 | chr7:19179256-19179855 | PANC-1 | pancreas: | n/a | chr7:19179593-19179609 chr7:19179726-19179735 chr7:19179593-19179609 chr7:19179363-19179377 chr7:19179594-19179608 |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:19164726..19167634-chr7:19176686..19178206,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000229533 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs578066513 | chr7:19178205-19178206 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs150171823 | chr7:19178241-19178242 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs183486051 | chr7:19178247-19178248 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs560753749 | chr7:19178254-19178255 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs527956764 | chr7:19178265-19178266 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs75753696 | chr7:19178275-19178276 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs138575176 | chr7:19178311-19178312 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs149298989 | chr7:19178354-19178355 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs11979718 | chr7:19178542-19178543 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs377758674 | chr7:19178582-19178583 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs78492099 | chr7:19179257-19179258 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs75599163 | chr7:19179263-19179264 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs79180391 | chr7:19179311-19179312 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs547090069 | chr7:19179312-19179313 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs373183381 | chr7:19179321-19179322 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs113353588 | chr7:19179410-19179411 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs565292846 | chr7:19179417-19179418 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs529697225 | chr7:19179439-19179440 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs532649793 | chr7:19179442-19179443 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs35048040 | chr7:19179492-19179493 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs548461335 | chr7:19179520-19179521 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs574796101 | chr7:19179543-19179544 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs111230116 | chr7:19179574-19179575 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs537233270 | chr7:19179592-19179593 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs143810064 | chr7:19179602-19179603 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs535738114 | chr7:19179620-19179621 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs562713132 | chr7:19179627-19179628 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs147253813 | chr7:19179636-19179637 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs78803669 | chr7:19179677-19179678 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs572464230 | chr7:19179723-19179724 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs542704033 | chr7:19179724-19179725 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs555223910 | chr7:19179739-19179740 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs185355148 | chr7:19179741-19179742 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs548707043 | chr7:19179779-19179780 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs544114461 | chr7:19179804-19179805 | Bivalent Enhancer Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs80352452 | chr7:19179825-19179826 | Bivalent Enhancer Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs557668342 | chr7:19179843-19179844 | Bivalent Enhancer Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs532573481 | chr7:19179859-19179860 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs79038426 | chr7:19179868-19179869 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs367869751 | chr7:19179876-19179877 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs117545517 | chr7:19179924-19179925 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs558839418 | chr7:19179938-19179939 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs547910343 | chr7:19179949-19179950 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs563312601 | chr7:19179989-19179990 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs552504199 | chr7:19180174-19180175 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs570620043 | chr7:19180178-19180179 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs181299892 | chr7:19180179-19180180 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs547911477 | chr7:19180271-19180272 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs566208028 | chr7:19180281-19180282 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs140726920 | chr7:19180297-19180298 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Biliary cancer | 19435499 | CNVD |
Cancer | 16751803 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Glioma | 21971842 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
colon cancer | 17210682 | CNVD |
Lung adenocarcinoma | 21810691 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Hypothalamic hamartomas | 18252217 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Leukemia | 23979775 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Autism | 22495311 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Prostate cancer | 19242612 | CNVD |
Autism | 18414403 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 21858162 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Cancer | 21637783 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16397240 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Heart disease | 21282601 | CNVD |
Rubinstein-Taybi syndrome | 22470819 | CNVD |
Alzheimer''s disease | 22166940 | CNVD |
Abnormal phenotypes | 18644119 | CNVD |
Non-syndromic sensorineural hearing loss | 22570644 | CNVD |
Cancer | 21183584 | CNVD |
Autism | 20808228 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:19178200-19178600 | Active TSS | Osteobl | bone |
2 | chr7:19179400-19179600 | Enhancers | Muscle Satellite Cultured Cells | -- |
3 | chr7:19179400-19180000 | Enhancers | HSMM | muscle |
4 | chr7:19179400-19180000 | Enhancers | HSMMtube | muscle |
5 | chr7:19179800-19180000 | Bivalent Enhancer | Primary hematopoietic stem cells | blood |